Surgery Partners, Inc.
SGRYSurgery Partners is a leading healthcare services provider in the United States, operating an integrated outpatient delivery model focused on surgical and ancillary care.
Earnings
Next report
Nov 9, 2026 (in 2 months)Valuation & ratios
Segments
Competitors
By market cap
By revenue growth
Profile
Surgery Partners is a leading healthcare services provider in the United States, operating an integrated outpatient delivery model focused on surgical and ancillary care. The company manages a national network of ambulatory surgery centers, surgical hospitals, and multi-specialty physician practices. Its core value proposition centers on providing high-quality, cost-effective surgical solutions in lower-cost settings compared to traditional acute care hospitals.
One of the largest and fastest-growing surgical services businesses in the U.S., leveraging a differentiated model of physician partnership and high-acuity procedure migration to outpatient settings.
FAQ
- What is Surgery Partners, Inc.'s market cap?
- Surgery Partners, Inc. (SGRY) has a market capitalization of $1.8B and trades on NASDAQ.
- What is Surgery Partners, Inc.'s revenue and profitability?
- Surgery Partners, Inc. generated $3.4B in trailing twelve-month revenue with a net loss of $88.6M, representing a net margin of -2.6%. Gross margin stands at 23.1%, with free cash flow of $187.6M. The latest reported period is Q2 2026.
- Who are Surgery Partners, Inc.'s competitors?
- Surgery Partners, Inc.'s key competitors include Tenet Healthcare Corporation, HCA Healthcare, Inc., Optum, Inc., and others. These companies compete in similar markets and product categories.
- Who does Surgery Partners, Inc. partner with?
- Surgery Partners, Inc.'s notable partners include The Joint Commission, Accreditation Association for Ambulatory Health Care.
- Where is Surgery Partners, Inc. headquartered?
- Surgery Partners, Inc. is headquartered in United States of America and employs approximately 13,500 people. It has been publicly traded since 2015.
